1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Some of the major drug makers' shares look appealing -- but others you might not want to touch with four-foot forceps.
Inflation fears have rocked the market's boat. But your portfolio doesn't have to capsize. These five stocks should help you weather rough waters no matter what the Fed decides to do with interest rates.
Investors looking for a high income stream often balk at closed-end funds (CEFs) because of their higher fees.
CEFs’ average annual fees sit at 1.09% (or $109 for every $10,000 invested),...
More Investing News »